SALIOGEN Synthetic Biology Trademark Application
Summary
USPTO recorded trademark application TM90517623 for SALIOGEN filed 2021-02-08 under Intent-to-Use basis. The application covers synthetic biology reagents, nucleic acids, nucleotides, pharmaceutical preparations for genetic therapies, and scientific research services in gene editing and cell line engineering.
What changed
USPTO published trademark application TM90517623 for SALIOGEN (intent-to-use basis) in Class 42 covering scientific reagents for research use, pharmaceutical preparations for genetic therapies treating neurology, oncology, and other conditions, and laboratory research services in gene/genome editing and engineering. The application explicitly excludes pharmaceuticals for xerostomia treatment.
This is an informational trademark filing with no compliance obligations for third parties. Competitors in synthetic biology, gene therapy development, or related pharmaceutical manufacturing should review the goods and services covered to identify potential conflicts with their own trademark filings or product lines.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
SALIOGEN
Intent to Use TM90517623 Kind: intenttouse Apr 02, 2026
Abstract
Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research; Pharmaceutical preparations for genetic therapies to treat genetically driven disorders in the fields of neurology, gastroenterology, metabolism, immunology, dyslipidaemia, the musculoskeletal system, oncology, and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes; all of the foregoing excluding pharmaceuticals for the treatment of xerostomia; Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development
Filing Date
2021-02-08
Related changes
Get daily alerts for USPTO Trademarks - Technology Services (Class 042)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Technology Services (Class 042) publishes new changes.